IDEXX LABORATORIES INC /DE — Director's Dealing 2017

Feb 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2017-02-16

Reporting Person: MCKEON BRIAN P (Executive VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-16	Common Stock	M	1880	$53.185	Acquired	38548	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-16	Incentive Stock Option (right-to-buy)	$53.185	M	1880	Disposed	2023-12-31	Common Stock (1880)	Direct

Footnotes

F1: This option vests in five equal annual installments, beginning on January 1, 2015. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.

F2: Not applicable.